Bryan King is professor of psychiatry and vice chair of child and adolescent psychiatry at the University of California, San Francisco.
Bryan King
Vice chair of psychiatry and behavioral sciences, University of Washington
From this contributor
Combination of strategies may tame autism’s placebo problem
Clinical trials of autism treatments are fertile ground for the placebo effect. Bryan King explains how the field must move forward to better evaluate treatments.
Combination of strategies may tame autism’s placebo problem
Explore more from The Transmitter
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.
This paper changed my life: Transformative work in addiction neuroscience
A 2011 Nature study found that loss of a nicotinic receptor subunit leads to increased nicotine intake in mice. The work set the standard for how to functionally validate genetic association study findings in neuroscience.
This paper changed my life: Transformative work in addiction neuroscience
A 2011 Nature study found that loss of a nicotinic receptor subunit leads to increased nicotine intake in mice. The work set the standard for how to functionally validate genetic association study findings in neuroscience.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.